GNPX
Price
$0.52
Change
-$0.03 (-5.45%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
5.74M
Intraday BUY SELL Signals
NCEL
Price
$3.54
Change
+$0.05 (+1.43%)
Updated
Jun 23, 04:58 PM (EDT)
Capitalization
19.06M
Intraday BUY SELL Signals
Interact to see
Advertisement

GNPX vs NCEL

GNPX vs NCEL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GNPX vs. NCEL commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNPX is a Hold and NCEL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (GNPX: $0.55 vs. NCEL: $3.49)
Brand notoriety: GNPX and NCEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNPX: 44% vs. NCEL: 51%
Market capitalization -- GNPX: $6.04M vs. NCEL: $18.79M
GNPX [@Biotechnology] is valued at $6.04M. NCEL’s [@Biotechnology] market capitalization is $18.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNPX’s FA Score shows that 1 FA rating(s) are green whileNCEL’s FA Score has 0 green FA rating(s).

  • GNPX’s FA Score: 1 green, 4 red.
  • NCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, NCEL is a better buy in the long-term than GNPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNPX’s TA Score shows that 5 TA indicator(s) are bullish while NCEL’s TA Score has 5 bullish TA indicator(s).

  • GNPX’s TA Score: 5 bullish, 2 bearish.
  • NCEL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, GNPX is a better buy in the short-term than NCEL.

Price Growth

GNPX (@Biotechnology) experienced а +13.52% price change this week, while NCEL (@Biotechnology) price change was +9.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NCEL($19.1M) has a higher market cap than GNPX($5.74M). NCEL YTD gains are higher at: 83.684 vs. GNPX (-68.434). GNPX has higher annual earnings (EBITDA): -16.01M vs. NCEL (-27.33M). GNPX (0) and NCEL (0) have equivalent revenues.
GNPXNCELGNPX / NCEL
Capitalization5.74M19.1M30%
EBITDA-16.01M-27.33M59%
Gain YTD-68.43483.684-82%
P/E Ratio0.08N/A-
Revenue00-
Total Cash18MN/A-
Total Debt279KN/A-
FUNDAMENTALS RATINGS
GNPX: Fundamental Ratings
GNPX
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GNPXNCEL
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
76%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GNPX
Daily Signal:
Gain/Loss:
NCEL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TII2.310.15
+6.94%
Titan Mining Corporation
MGY27.130.72
+2.73%
Magnolia Oil & Gas Corp
VALE15.710.29
+1.88%
Vale SA
AIIR6.70-0.30
-4.29%
Air Global Plc
ATOS1.83-0.18
-8.96%
Atossa Therapeutics Inc.

GNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNPX has been closely correlated with CANF. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if GNPX jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNPX
1D Price
Change %
GNPX100%
-6.69%
CANF - GNPX
93%
Closely correlated
+2.68%
APVO - GNPX
91%
Closely correlated
+2.57%
ICU - GNPX
87%
Closely correlated
+3.69%
MLEC - GNPX
86%
Closely correlated
-2.32%
LNAI - GNPX
84%
Closely correlated
+10.58%
More

NCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NCEL has been loosely correlated with CANF. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if NCEL jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NCEL
1D Price
Change %
NCEL100%
+5.44%
CANF - NCEL
62%
Loosely correlated
+2.68%
APVO - NCEL
62%
Loosely correlated
+2.57%
GNPX - NCEL
60%
Loosely correlated
-6.69%
MLEC - NCEL
58%
Loosely correlated
-2.32%
IRON - NCEL
54%
Loosely correlated
-0.13%
More